Ref Author/s Title Publication Volume Page Year Sent to CRUK
2009/004 D. Cooke, S.J. Hurel, A. Casbard, L. Steed, S. Walker, S. Meredith, A.J. Nunn, A. Manca, M. Sculpher, M. Barnard, D. Kerr, J.U. Weaver, J. Ahlquist, S.P. Newman Randomised Controlled Trial to Assess the Impact of Continuous Glucose Monitoring on HbA1c in Insulin-Treated Diabetes (MITRE Study) Diabetic Medicine dio:10.1111/j.1464-5491 Paper 2009
2009/003 C. A. Llewelyn,* A. W. Wells, M. Amin,* A. Casbard,! A. J. Johnson,§ S. Ballard,* J. Buck,*M. Malfroy,* M. F. Murphy¶&L.M. Williamson** *National Blood Service (NBS)/Medical Research Council Clinical The EASTR study: a new approach to determine the reasons for transfusion in epidemiological studies Transfusion Medicine 2009 19: 89-98 Paper 2009 >
2009/002 S Dorman, C Jolley, A Abernethy, D Currow, M Johnson, M Farquhar, G Griffiths, T Peel, S Moosavi, A Byrne, AWilcock, L Alloway, C Bausewein, I Higginson and S Booth Researching breathlessness in palliative care: consensus statement of the National Cancer Research Institute Palliative Care Breathlessness Subgroup Palliat Med 2009 23; 213-217 Paper 2009
2009/001 David Sebag-Monterfiore, Richard J Stephenson, Robert Steele,John Monson, Robert Grieve, Subhash Khanna, Phil Quirke, Jean Couture, Catherine De Mertz, Arthur Sun Myint, Eric Bessell, Gareth Griffiths, Lindsay C Thompson, Mahesh Parmar, on behalf of all the trial collaborators* Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CRO7 and NCIC-CTG C016) : a multicentre, randomised trial Lancet 2009 373: 811-20 Paper 2009
Ref Author/s Title Publication Volume Page Year Sent to CRUK
2008/015 Lisette Nixon, Lucy Wills, John Staffurth, Tom Crosby, Angela Casbard and Gareth Griffiths Implementation of Q A sub study for SCOPE 1; preliminary results for test cases Clinical Trials in Radiotherapy >13th May 2008, London Abstract(oral poster) 2008
2008/014 Macbeth F, Noble S, Burns S, Moore B and Griffiths G FRAGMATIC: A Randomised Phase III Clinical Trial Investigating the Effect of FRAGMin added to Standard Therapy in Patients with Lung Cancer 3rd Annual Research and Development Conference 2008 P:36,37 Poster 2008 09/04/2009
2008/013 Lisette Nixon, Lucy Wills, John Staffurth, Tom Crosby, Angela Casbard, Tim Maughan, Gareth Griffiths Implementation of Quality Assurance of Radiotherapy in the NCRI SCOPE 1 trial, a study of chemoradiation in oesophageal cancer plus or minus cetuximab Wales Cancer Conference 2008 P:37 Abstract 2008
2008/012 Johnson, H. Nelson, A. The Acceptability of Information Leaflet Explaining Cardiopulmonary Resuscitation Policy in the Hospice Setting A Qualitative Study Exploring Patients Views Palliative Medicine 2008 22: 647-652 Journal 2008
2008/011 Alexander J. Taylor, Jeffery R. Lee, Venus M.-W. H, Robert Flick, Ruhena Chowdhury and G. Angus McQuibban. Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinsons disease factors Pink1 and ParkinDis. Model. Mech. 2008 Mech.2008 1:168-174 Journal 2008
2008/010 Bryne,A ; Hood,K ; Griffiths, G; Maughan T Design and Conduct of Research and Clinical Trials Declan Walsh Palliative Medicine >Chapter 28. Journal 2008
2008/009 Dr Annmarie Nelson Introducing qualitative methodologies to a CR-UK accredited Trials Unit Award/Chira/lQuic Conference Poster 2008
2008/008 Noble SIR, Nelson A, Finlay IG Factors influencing hospice thromboprophylaxis policy: a qualitative study Palliative Medicine >2008,22(7):808-13 Journal 2008
2008/007 Edmond KM, Quigley MA, Zandoh C, Danso S, Hurt C, Owusu Agyei S, Kirkwood BR Aetiology of stillbirths and neonatal deaths in rural Ghana: implications for health programming in developing countries Paediatric and Perinatal Epidemiology; 2008:22;430-437. Journal 2008
2008/006 Edmond KM, Quigley MA, Zandoh C, Danso S, Hurt C, Owusu Agyei S, Kirkwood BR Diagnostic accuracy of verbal autopsies in ascertaining the causes of stillbirths and neonatal deaths in rural Ghana Paediatric and Perinatal Epidemiology; 2008:22;417-429. Journal 2008
2008/005 Noble SIR, Li J, Nelson A, Finlay IG. Factors that influence the management of end of life care in the Peoples Republic of China Palliative Medicine 22;406 Oral Presentation 2008
2008/004 Noble SIR, Nelson A, Finlay IG Factors influencing hospice thromboprophylaxis policy Palliative Medicine 22; 536 Poster 2008
2008/003 S.J. Harland, H.Kynaston, K. Grigor, D.M. Wallace, C. Beacock, R. Kockelbergh, S. Clawson, T. Barlow, M.K. Parmar and G.O.Griffiths; National Cancer Research Institute Bladder Clinical Studies Group A Randomized Trial of Radical Radiotherapy for the Management of pT1G3 NXMO Transitional Cell Carcinoma of the Bladder The Journal of Urology Vol.179,1639-1642, April 2008 Letters to the Editor/Errata 2008
2008/002 S.I.R. Noble, A. Nelson Marie and I.G.Finlay Challenges faced by palliative care physicians when careing for doctors with advanced cancer Palliate Med 2008 22,71-76 DOI:1177/0269216307084607 Full Paper 2008
2008/001 Gareth Griffiths Clinical Trials in Oncology Medicine >Volume 36, 1st January 2008 Abstract 2008
Ref Author/s Title Publication Volume Page Year Sent to CRUK
2007/96 Harland, S.J. Kynaston, H. Grigor, K. Wallace, D.M. Beacock, C. Kockelbergh, R. Clawson, S. Barlow, T. Palmer, M.K.B. Griffiths, G.O. National Cancer Research Institute Bladder Clinical Studies Group A Randomized Trial of Radical Radiotherapy for the Management of pT1G3 NXMO Transitional Cell Carcinoma of the Bladder The American Urological Association, Inc. Volume 178(3) Abstract 2007
2007/95 Paul. H.S.Shaw, Tim. S. Maughan and Alan. R. Clarke Utilising mouse models of colon cancer to predict response to Anti-EGFR therapy and improve understanding of biological mechanisms of resistance CRUK meeting Oxford 2007 Abstract 2007
2007/94 G. Folprecht, M. T. Seymour, L. Saltz, J.-Y. Douillard, R. J. Stephens, E. Van Cutsem, P. Rougier, T. S. Maughan C.-H. Köhne for the irinotecan metaanalysis group. Irinotecan/5-FU/FA (I-FU) or 5-FU/FA (FU) first line therapy in older and younger patients with metastatic colorectal cancer: Combined analysis of 2,691 patients in randomized controlled trials ASCO 2007 > Abstract 2007
2007/93 TS.Maughan on behalf of the COIN Trial Management Group & Investigators. Cetuximab (C), oxaliplatin (Ox) and fluoropyrimidine (Fp): toxicity during the first 12 weeks of treatment for the first 804 patients entered into the MRC COIN (CR10) trial. ASCO 2007 Abstract 2007
2007/92 Seymour MT, Maughan TS, Wasan HS, Brewster AE, Shepherd SF, O'Mahoney MS, May BR, Thompson LC, Meade, Langley RE, for the UK NCRI Colorectal Clinical Studies Group and FOCUS2 Investigators. Chemotherapy choices and doses in frail and elderly patients with advanced colorectal cancer: an MRC randomised clinical trial FOCUS2 ECCO conference 2007 Abstract 2007
2007/91 S. Mukherjee, E. Hudson, S. Reza, M. Thomas,* T. Crosby, T. Maughan A review of outcome of pancreatic cancer within a UK cancer network with special emphasis on locally advanced non-metastatic pancreatic cancer (LANPC) accepted Clinical Oncology 2007 july 2007
2007/90 Hudson E, Powell J, Mukherjee S, Crosby TD, Brewster AE, Maughan TS, Bailey H, Lester JF Small cell oesophageal carcinoma: an institutional experience and review of the literature Br J Cancer. 2007 Mar 12;96(5) 708-11 2007
2007/89 Mashayekhi S.O., Ghandforoush-sattari M.R., Hain R.W.D., Nixon L.S. Morphine-6-glucuronide assay using a competitive ELISA assay Pharmaceutical Sciences Spring 2007 51-60. 2007
2007/88 Bolton CE, Broekhuizen R, Ionescu AA, Nixon LS, Wouters EF, Shale DJ, Schols AM. Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD Thorax. 2007 Feb;62(2): 109-14 Epub 2006 Aug 23. 2007
2007/87 R Glynne-Jones1, S Falk2, TS Maughan3, HM Meadows4 and D Sebag-Montefiore5 A phase I/II study of Irinotecan when added to 5-Fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: A Colorectal Clinical Oncology Group (CCOG) Study Br J Cancer 96, 551-8 2007 (IF 4.459) 2007
2007/86 Matthew T. Seymour, Timothy S. Maughan, Jonathan Ledermann, Clare Topham, Roger James, Stephen Gwyther, David B. Smith, Stephen Shepherd, Anthony Maraveyas, David R. Ferry, Angela M. Meade, Lindsay Thompson, Gareth Griffiths, Mahesh K.B. Parmar, and Richard J. Stephens for the FOCUS Trial Investigators and the National Cancer Research Institute Colorectal Clinical Studies Group Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial. Lancet 2007 15.4166666666667 143-152(IF.17.49) 2007
2007/86Adams RA & Maughan TS. Predicting response to epidermal growth factor receptor targeted therapy in colorectal cancer. Expert Reviews in Anticancer Therapy 7 (4), 503-518, 2007 (IF 4.059) 2007
2007/85 Adams RA & Maughan TS Predicting response to epidermal growth factor receptor targeted therapy in colorectal cancer. Expert Reviews in Anticancer Therapy 7 (4) 4 503-518
2007/84 Ghevaert C, Campbell K, Stafford P, Metcalfe P, Casbard A, Smith GA, Allen D, Ranasinghe E, Williamson LM, Ouwehand WH. HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia. Transfusion. 2007 Jul;47(7): 1296-305. 2007
2007/83 Mathew T Seymour, Timothy S Maughan, Jonathan A Leadermann, Clare Topham, Roger James, Stephen J Gwyther, David B Smith, Stephen Shepherd, Anthony Maraveyas, David R Ferry, Angela M Meade, Lindsay Thompson, Gareth O Griffiths, Mahesh K B Parmer, and Richard J Stephens, for the FOCUS Trial investigators* and the National Cancer Research Institute Colorectal Clinical Studies Group Different Strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial The Lancet >Vol 370 Pages 143-152 July 14th, 2007
2007/82 Dr Tom Crosby, Dr Lisette Nixon, Dr Chrisopher Cotterill-Jones and Gareth Griffiths on behalf of the SCOPE 1 Trial Management Group, Wales Cancer Trials Unit, Velindre NHS Trust, Cardiff SCOPE 1 : Study of Chemoradiotherpy in Oesophageal Cancer Plus or minus Erbitux Cardiff University EU Clinical Trials Day Poster 2007
2007/81 Dr Tom Crosby, Dr Lisette Nixon, Dr Chrisopher Cotterill-Jones and Gareth Griffiths on behalf of the SCOPE 1 Trial Management Group, Wales Cancer Trials Unit, Velindre NHS Trust, Cardiff SCOPE 1 : Study of Chemoradiotherpy in Oesophageal Cancer Plus or minus Erbitux Velindre NHS Trust R & D Conference Abstract 2007
2007/80 Dr Annmarie Nelson: Marie Curie Senior Palliative Care Research Fellow Wales Cancer Trials Unit: Qualitative Research Poster 2007
2007/79 Chief Investigator: Professor Alison Fiander, Co-investigator: Dr. Amanda Tristram, Scientific Lead: Chris Hurt, Trial Manager: Helen Phillips, Data Manager: Sarah Hunt RT3VIN - A randomised phase 11 multi-centre trial of topical treatment in women with vulval intraepithelial neoplasia Poster 2007
2007/78 Lloyd-Richards C, Nelson A, Noble SIR (2007). A Stress in non clinical palliative care staff: the medical secretarys experience. European Journal of Palliative Care; Abstracts of the 10th Congress of the European Association of Palliative Care Abstract 2007
2007/77 Dr Annmarie Nelson, Marie Curie Hospice, Holme Tower. Wales Cancer Trials Unit, Cardiff Half dead or half alive? Factors affecting acceptance of terminal illness and dying. EAPC Conference, Budapest Poster 2007
2007/76 Annmarie Nelson, Wales Cancer Trials Unit/Marie Curie Cancer Care. Gareth Griffiths, Wales Cancer Trials Unit. Anthony Burne, Clinical trials in palliative care: Marie Curie Cancer Care in collaboration with Wales Cancer Trials Unite. Marie Curie Research Conference, Royal Society of Medicine. 2007 > Poster 2007
2007/75 Dr Annmarie Nelson. Marie Curie Hospice, Holme Tower, Wales Cancer Trials Unit. Cardiff Half dead or half alive? Factors affecting acceptance of terminal illness and dying Journal of the Royal Society of Medicine Abstract 2007
2007/74 Dr. HM Johnson BM BCh MRCGP MSc, Associate Specialist, Myton Hamlet Hospice, Warwick. Dr A Nelson BA (Hons) PhD, Marie Curie Palliative Care Senior Research Fellow, Wales Cancer Trials Unit, Cardiff. The Acceptability of an Information Leaflet Explaining Cardiopulmonary Resuscitation Policy in the Hospice Setting A Qualitative Study Exploring Patients' Views In submission to Palliative Medicine Full Paper 2007
2007/73 Noble SIR, Senior Lecturer Palliative Medicine, Cardiff University Royal Gwent Hospital, Wales. Nelson A, Marie Curie Palliative Care Senior Research Fellow, Wales Cancer Trials Unit, Cardiff. Finlay IG, Professor of Palliative Medicine, Cardiff University and University of Groningen The challenges faced by palliative care physicians when caring in submission to doctors with advanced cancer Palliative Medicine Full Paper 2007
2007/72 Murphy MF, Casbard AC, Ballard S, Shulman IA, Heddle N, Aubuchon JP, Wendel S, Thomson A, Hervig T, Downes K, Carey PM, Dzik WH; BEST Research Collaborative. Prevention of bedside errors in transfusion medicine (PROBE-TM) study: a cluster-randomized, matched-paired clinical areas trial of a simple intervention to reduce errors in the pretransfusion bedside check. Transfusion. 2007 >May;47(5) 771-80. 2007
Ref Author/s Title Publication Volume Page Year Sent to CRUK
2006/71 Noble, S. and Nelson, A. Palliative care can include prophylaxis Nursing Times 102 (14) 16. Paper 2006
2006/70 Evans TRJ, E Wylie, JJ Curto Garcia, FY Coxon, LR Wall, MM Eatock, TS Maughan, MS Highley, P Butzberger Capecitabine (X) and oxaliplatin (O) combination chemotherapy in patients (pts) with advanced gall bladder or biliary tract cancer: a phase II study submitted ESMO 2006) Abstract 2006
2006/69 Sue Rees, Sarah Townsend and Gareth Griffiths. Wales Cancer Trials Unit, Cardiff, Velindre NHS Trust Development of A Sponsorship Model Velindre NHS Trust - Inaugural Research & Development Conference 2006 Poster and abstract 2006
2006/68 Dr Peter Barrett-Lee, Dr Jacinta Abraham, Sue Rees and Gareth Griffiths Velindre NHS Trust Sponsorship - Chief investigator's Perspective Zoledronate versus Ibondronate Comparative Evaluation, in metastatic breast cancer patients. Velindre NHS Trust - Inaugural Research & Development Conference 2006 Presentation and abstract 2006
2006/67 Richard A Adams, Matthew Morgan, Somnath Mukherjee, Alison E Brewster, Tim S Maughan, Dave Morrey, Tim Havard, Wyn Lewis, Geoff Clarke, S Ashley Roberts, L Vachtsevanos, J Leong, Richard Hardwick, David Carey, and Tom D.L Crosby A prospective comparison of multidisciplinary treatment of oesophageal cancer with curative intent in a UK cancer network. Eur J Surg Oncol. 2006 Nov 21 IF 4.167) 2006
2006/66 Ionescu AA, Mickleborough TD, Bolton CE, Lindley MR, Nixon LS, Dunseath G, Luzio S, Owens DR, Shale DJ. The systemic inflammatory response to exercise in adults with cystic fibrosis. J Cyst Fibros May;5(2): 105-12. Epub 2006 Jan 3. 2006
2006/65 Cassidy J, Douillard J-Y, Twelves C, McKendrick JJ, Scheithauer W, Bustová I, Johnston PG, Lesniewski-Kmak K, Jelic S, Fountzilas G, Coxon F, Díaz-Rubio E, Maughan TS, Malzyner A, Bertetto O, Beham A, Figer A, Dufour P, Patel KK, Cowell W, Garrison Pharmaco-economic analysis of adjuvant oral capecitabine versus intravenous 5-FU/LV in Dukes C colon cancer: the X-ACT trial Br J Cancer 38899 IF 4.459) 2006
2006/64 A. P. Jekunen, C. Cotterill-Jones, P. Dewland, T. Tanner, H. Sikorska, L. Asking, and T. Jouhikainen (2006). Dose linearity of inhaled fentanyl (FT) with comparative pharmacokinetics to transmucosal fentanyl (A). ASCO Meeting 24: 8629. Abstracts 2006
2006/63 Johnson, H. Nelson, A. (2006) The acceptability of an information leaflet explaining cardio-pulmonary resuscitation (CPR) policy in the hospice setting: A qualitative study exploring patients' views Annual Marie Curie research meeting. Royal Society of Medicine. London. Abstract 2006
2006/62 Nelson, A. Noble, S. Bekkers, M.J. (2006) Constructions of identity: Tensions between professional and personal experience in research interviews with senior palliative care doctors and nurses. Improving our understanding Annual Marie Curie Research Meeting, London Abstract 2006
2006/61 Noble, S., Turner, C., Nelson, A. and Finlay, I. (2006) Acceptability of low molecular weight heparin thromboprophylaxis for inpatients receiving palliative care: Qualitative study British Medical Journal 332 (7541): 577-80. Full Papers 2006
2006/60 Noble, S., Nelson, A., Turner, C. and Finlay, I. (2006 Thromboprophylaxis in advanced malignancy: Thematic analysis of inpatient interviews Palliative Medicine 20 (2) 156. Abstract 2006
2006/59 Nelson, A. and Noble, S. (2006) professions. P One of our own: Common themes and differences occurring when palliative care doctors and nurses treat patients of the same Palliative Medicine 1.06875 Paper 2006
2006/58 Noble, S., Nelson, A. and Finlay, I. (2006) One of our own: The challenges of caring for doctors with advanced cancer. Palliative Medicine >20 (2) 156. Abstract 2006
2006/57 Nelson, A., Noble, S. and Finlay, I. (2006) One of our own: The challenges of caring for nurses with advanced cancer. Palliative Medicine >20 (2) 154. Abstract 2006
2006/56 Noble, S., Turner, C., Nelson A and Finlay I (2005) How does thromboprophylaxis impact on the quality of life of inpatients with advanced malignancy? Haematologica Reports 1(9): 99 Abstract 2006
2006/55 A.P. Jekunen, C. Cotterill-Jones, P. Dewlan, T.Tanner, H. Sikprsla, L Asking, T.Jouhikainen; LABPharma, Turku, Finland; Simbec Research, London, United Kingdom Dose linearity of inhaled fentanyl (FT) with comparative pharmacokinetics to transmucosal fentanyl (A) Proceedings of ASCO 24 Abstract 8629 2006
2006/54 P.Quirke, D.Sebag-Montefiore, R. Steele, S Khanna, J Monson, A Holiday, L Thompson, G Griffiths, R Stephens for the NCRI colorectal cancer study group and CRO 7 participants; MRC Clinical Trial Unit, London, United Kingdom Local recurrence after rectal cancer resection is strongly related to the plane of surgical dissection and is further reduced by pre-operative short course radiotherapy. Preliminary results of the Medical Research Council (MRC) CR07 trial Proceedings of ASCO 24 Abstract 3512 2006
2006/53 Dr Tom Crosby, Dr Lisette Nixon, Dr Christopher Cotterill-Jones and Gareth Griffiths on behalf of the SCOPE 1 Trial Management Group, Wales Cancer Trials Unit, Velindre NHS Trust, Cardiff SCOPE 1 : Study of Chemoradiotherpy in Oesophageal Cancer Plus or minus Erbitux Velindre NHS Trust - Inaugural Research & Development Conference 2006 Poster 2006
2006/52 D.Sebag-Montefiore, R Steele, P Quirke, R Grieve, S Khanna, J Monson, A Holiday, L Thompson, G Griffiths, R Stephens for the NCRI colorectal cancer study group and CRO 7 participants; MRO Clinical Trial Unit, London, United Kingdom Routine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer Proceedings of ASCO 24 Abstract 3511 2006
2006/51 Stanworth SJ, Dyer C, Casbard A, Murphy MF. Feasibility and usefulness of self-assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleeding. Vox Sang. >2006 Jul;91(1) :63-9. 2006
2006/50 Davies A, Staves J, Kay J, Casbard A, Murphy MF End-to-end electronic control of the hospital transfusion process to increase the safety of blood transfusion: strengths and weaknesses. Transfusion. 2006 2006 Mar;46(3): 352-64. 2006
2006/48 Patkar V., Hurt C., Steele R., Love S., Purushotham A., Williams M.,Thomson R., Fox J. Evidence-based guidelines and decision support services: a discussion and evaluation in triple assessment of suspected breast cancer British Journal of Cancer 95 1490-1496 2006